Latest Breaking News On - Steve sugino - Page 1 : comparemela.com

BMS pays Zenas $50m upfront for regional rights to autoimmune disease antibody

BMS pays Zenas $50m upfront for regional rights to autoimmune disease antibody
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

South koreaHong kongZenas biopharmaSteve suginoBristol myers squibbUniversity of oxfordBristol myersMyers squibbLonnie moulder

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obex

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

South koreaHong kongUnited statesZenas biopharmaCoozenas biopharmaSteve suginoBristol myers squibb companyXencor incBristol myers squibbRelated diseaseAuto immune hemolytic anemiaLonnie moulderChief executive officerSenior vice presidentGeneral managerBristol myers

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesHong kongBaden wübergSteve suginoZenasbiopharmaand linkedinZenas biopharmaBristol myers squibbBristol myers squibb companyXencor incRelated diseaseAuto immune hemolytic anemiaLonnie moulderChief executive officerSenior vice presidentGeneral manager

PhRMA Promotes Cluster Concept In Japan Reform Wish List

PhRMA Promotes Cluster Concept In Japan Reform Wish List
informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.

United statesSteve suginoRamona sequeiraFumio kishidaHans klemmJapan business federation keidanrenResearch manufacturers of america phMinistry of healthJapan research instituteShonan health innovation parkGlobal portfolio divisionTakeda pharmaceutical coChordia therapeutics incAmgen incJapan pharmaceutical manufacturers associationCommittee on bioeconomy

LUMAKRAS® (SOTORASIB) RECEIVES APPROVAL IN JAPAN FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER

/PRNewswire/ Amgen (NASDAQ: AMGN) today announced that LUMAKRAS® (sotorasib) has been approved in Japan for the treatment of KRAS G12C-mutated positive,.

United statesHong kongUnited kingdomSaudi arabia generalSaudi arabiaUnited arab emiratesPuerto ricoMinistry of healthSouth koreaGreat britainMichael strapazonSteve suginoMegan foxAstellas pharmaAmgen astellas biopharmaSpira al